AstraZeneca PLC
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Core EPS: $9.16 in FY2025, up 11.6% from a year earlier.
Latest, FY2025
9.16
Period ended Dec 31, 2025
Change on a year earlier
+11.6%
8.21 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Where the FY2025 figure comes from
“|| EPS | $6.60 | $0.11 | $2.26 | $0.19 | $9.16 | 12 | 11”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K Quarterly & Form 20-F Core Financial Measures.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Core EPS ($ per share) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9.16 | +11.6% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 8.21 | +13.1% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 7.26 | +9.0% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 6.66 | +25.9% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 5.29 | +31.6% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 4.02 | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Breakdown
What makes up core EPS
Cite this data
StockData. (2026). AstraZeneca Core EPS ($), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/core-eps
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.